Perspective Therapeutics
CATX
24 hedge funds and large institutions have $3.89M invested in Perspective Therapeutics in 2016 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 4 closing their positions.
0.01% more ownership
Funds ownership: 0.78% → 0.79% (+0.01%)
3% less capital invested
Capital invested by funds: $4.02M → $3.89M (-$128K)
8% less funds holding
Funds holding: 26 → 24 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$82K |
| 2 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$23.6K |
| 3 |
Wells Fargo
San Francisco,
California
|
+$2.36K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$787 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$23.9K |
| 2 |
LPL Financial
San Diego,
California
|
-$17K |
| 3 |
RCM
Rotella Capital Management
Bellevue,
Washington
|
-$16K |
| 4 |
Goldman Sachs
New York
|
-$11K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$8.28K |
CATX Hedge Fund Activity: Q1 2016 in Review
24 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q1 2016, worth a combined $3.89M — down 3.2% from $4.02M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of CATX and 2 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 2 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $82K. The largest seller was UBS Group, cutting an estimated $23.9K.
- 24 institutional investors held Perspective Therapeutics (CATX) as of Q1 2016, down from 26 in Q4 2015.
- Funds reported $3.89M of Perspective Therapeutics stock for Q1 2016, down 3.2% quarter-over-quarter.
- 2 funds opened new Perspective Therapeutics positions in Q1 2016 and 4 closed out, a net change of -2 holders.
- The largest Perspective Therapeutics buyer in Q1 2016 was Citadel Advisors, an estimated $82K added.
- The largest Perspective Therapeutics seller in Q1 2016 was UBS Group, an estimated $23.9K sold.
Based on aggregated 13F filings for Q1 2016.